BY ALBERT RONNING-ANDERSSON
-
Novo Nordisk supports US biotech company with focus on CNS
This is Novo Nordisk’s 2nd financial investment within the Danish pharmaceutical business’s financial investment program called Science2Medicine Innvest.
-
Sonova’s CFO stepping down – replacement found
The globe’s biggest listening devices firm requires a brand-new financing principal by July 2025 after the present CFO surrendered to go after a board profession outside the …
-
Concrete slab saved Novo Nordisk from explosion at building site
Novo Nordisk decreases to comment cops record info concerning ammonia and gas containers saved in a burning structure in Kalundborg.
-
Allergy Therapeutics gets good trial data with peanut vaccine
UK-based Allergic Reaction Rehabs has Stage 1 information for its peanut allergic reaction vaccination revealing great efficiency in 12 peanut sensitive people.
-
EU launches payment model for new antibiotics
The program intends to battle antimicrobial resistance and develop financial motivations for the pharmaceutical sector, with an unique concentrate on smaller sized EU participant s…
-
Coloplast re-elects board of directors at annual general meeting
This indicates that chairman Lars Rasmussen, that offered most of his shares in Coloplast in September, will certainly continue the board.
-
Novo Holdings invests an additional USD 161m in US biotech company
With the funding shot, Nuvig Rehabs can launch stage II tests with its lead prospect and advancement the preclinical pipe.
-
EU launches payment model for new antibiotics
The program aims to combat antimicrobial resistance and create economic incentives for the pharmaceutical industry, with a special focus on smaller EU member states.
-
Advisors recommend Novo Nordisk to leave Russia
Although Novo Nordisk’s sales in Russia are made with humanitarianism in mind, organization indirectly adds tax obligation earnings that money the battle in Ukraine, state ex…
-
Genmab secures rights to second Scancell antibody in new million-dollar deal
An arrangement in between Genmab and UK-based Scancell consists of an in advance repayment and prospective growth, governing and industrial landmark settlements of as much as USD 6…